Infertility is a growing epidemic, affecting one in four couples in developing countries and 48.5 million couples worldwide. In vitro fertilization (IVF) offers hope, but its potential remains underutilized with unpredictable outcomes and limited access to care. However, the integration of artificial intelligence (AI) into the IVF process is set to revolutionize fertility treatments.
Currently, IVF success rates stand around 30% per cycle, with many patients requiring multiple cycles to achieve a live birth. Factors such as age and clinician expertise significantly influence outcomes. To address these challenges, AI-driven startups like Fairtility, Emrbyonics, Mojo, and ALife are developing solutions to analyze embryos, assess sperm quality, and personalize IVF treatment plans.
Fairtility’s AI-based system, CHLOE, uses computer vision algorithms to predict the effectiveness of embryo implantations. With over 200,000 embryo videos and 5 million clinical data points, the AI model can analyze features often undetectable by even experienced embryologists. CHLOE’s algorithms can predict blastulation with 96% accuracy, implantation with 71% accuracy, and genetic health with 69% accuracy.
However, AI should not replace embryologists and clinicians but rather augment their decision-making. To maximize AI’s impact, data availability, workflow integration, and trust in the technology must be addressed. Despite the challenges, AI integration has the potential to significantly improve IVF success rates, increase access to care, and change the future of fertility treatments. As a result, millions of couples struggling with infertility could benefit from these cutting-edge AI solutions in the near future.
To learn more check out the full article on Forbes